Filter
99
Filtered Results: 99
Text search:
postinfection
Featured
Recommendations
10
New Publications
19
Language
Document type
No document type
39
Guidelines
28
Studies & Reports
12
Manuals
9
Training Material
4
Fact sheets
3
Strategic & Response Plan
2
Brochures
1
Infographics
1
Countries / Regions
Global
7
India
4
South Africa
3
Ethiopia
3
Liberia
3
Colombia
2
Kenya
2
Senegal
2
Burkina Faso
2
Latin America and the Carribbean
2
Germany
2
Uganda
2
South Sudan
2
Sierra Leone
1
Rwanda
1
Nigeria
1
Burundi
1
Peru
1
Malawi
1
Philippines
1
Africa
1
Dominican Republic
1
West and Central Africa
1
Western and Central Europe
1
Somalia
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
5
Guidelines
5
Capacity Building
5
Maternal & Child Health
3
Policies
3
NTDs & Others
3
Maternal Health
3
COVID-19
2
MPOX - Monkeypox
2
Infection Control & Prevention (IPC)
2
Pediatrics
2
Demograhic Health Surveys DHS
2
Drugs & Medical Equipment
2
Women & Child Health
2
Studies & Reports
2
Surgery & Anaesthesia
2
Non-communicable Diseases
2
Disease Prevention & Control
2
Reproductive Health
2
Communicable Diseases
1
Paediatrics
1
Family Planning
1
Disaster Preparedness
1
Virology
1
Public Health
1
Vaccine-preventable Diseases
1
Chagas
1
Hemorrhagic Fever
1
Diarrhoeal Disease/Cholera
1
Yellow Fever
1
Information, Education and Communication (IEC)
1
Other
1
WASH
1
General Guidelines
1
Needs Assessment
1
HIV & STI
1
Malaria
1
Toolboxes
Clinical Guidelines
4
Assessment & Studies
3
Clinical Aspects, Treatment & Prevention
3
Research
3
International
3
Laboratory
3
Infection Control General
3
Long COVID/ Post-COVID Syndrome
3
Clinical Aspects & Diagnostics
3
HIV surveillance
2
Context & Facts, Travel Advice
2
Diagnostics & Laboratory Guidance
2
Clinical Guidelines
2
Country specific documents
2
Hospital Readiness/Essential Health Services
2
MPOX - Monkeypox
2
Neurological Disorders
2
Clinical Guidelines
2
Antiretroviral Treatment ART
2
Chikungunya
2
Meningitis & Encephalitis
2
Treatment Guidelines
1
Country specific
1
Key Resources
1
Influenza Prevention & Control
1
Context, Facts & Travel Advice
1
Social Mobilisation
1
Public Health
1
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
1
Children/Adolescents Mental Disorders
1
Children
1
Epilepsy
1
General
1
Clinical Guidelines
1
Context & Facts
1
Treatment Guidelines
1
Prevention & Preparedness
1
Health Personnel
1
Public Health
1
Surveillance & Contact tracing
1
For General Public & Community
1
Training, others
1
Faith-based Organizations
1
For Health Worker
1
Appeals and Response Plans
1
Global Impact: Socio-economic, health services, TB & HIV
1
Human Rights
1
Camps and Camp-like Settings
1
Paediatrics
1
Medical & Community Masks
1
Situation Reports COVID-19
1
Access & Strategy
1
Immunization Guidelines
1
SARS-CoV-2 Variants
1
Biontech/Pfizer Comirnaty
1
Others
1
Others
1
Peru
1
Booster Doses
1
Essential Medicines & Devices Lists
1
Women & Maternal Health
1
Surgery
1
Epilepsy
1
Chagas
1
Disability Prevention & Rehabilitation
1
Information & Education Material (IEC)
1
NTDs General
1
Overview, Studies & Reports
1
Access to treatment and laboratory
1
Health Worker
1
Women
1
Information & Education Material (IEC)
1
Policies and guidelines
1
Co-Morbidities (except TB)
1
Asia
1
Prevention of mother-to-child transmission (PMTCT)
1
Research & Access
1
Germany
1
Dengue Prevention & Control
1
General Public
1
Testing Guidelines
1
Chikungunya Prevention & Control
1
TB
1
Neurological disorders, Others
1
Clinical Infectious Diseases, cix705, https://doi.org/10.1093/cid/cix705
Information Note
Advice for countries using or planning
to introduce dual HIV/syphilis RDT in antenatal services and other testing sites.
WHO/RHR/17.01
Cholera is an acute diarrhoeal disease caused by the ingestion of food or water contaminated with the bacterium V.
cholerae. It has a short incubation period of a few hours to 5 days. It is endemic in some countries, frequently
showing seasonal variations in the number of reported cases. Cholera a...
It is recommended that egg based quadrivalent vaccines for use in the 2019-2020 northern hemisphere influenza season contain the following:
an A/Brisbane/02/2018 (H1N1)pdm09-like virus;
an A(H3N2) virus to be announced on 21 March 2019*;
a B/Colorado/06/2017-like virus (B/Victoria/...
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
Accessed: 11.03.2019
htb supplement: 2018 Vol 19:(1)
New drugs in development
July 2018
www.i-Base.info
Accessed Febr. 6, 2020
Updated on 6 APRIL 2020
There are serious concerns that the situation might escalate in the next weeks modelling the epi curve of other regions. The interlinkages between human mobility and the current pandemic of COVID-19 are well established, and while international flights have been suspended i...
10 May 2021
This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020.
This update is focused on what is currently understood about SARS-CoV-2 immunity from natural infection. More information about considera...
The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is ...
13 July 2021. Eid al Adha is a festival during which Muslim families and friends unite to pray together and give alms, especially in the form of sacrificed animal meat. In light of the COVID-19 pandemic, this document highlights public health advice for social gatherings and religious practices that...
The COVID-19 pandemic’s immediate costs, measured in lives lost and damaged, have been appalling and continue to rise. In addition, its effects on individuals’ livelihoods and economies around the world have been deep and are likely to be long lasting. While saving lives was the near-exclusive f...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...
